Formulation and Delivery - Biomolecular

(T0930-01-01) Capsugel® Enprotect® Capsules Filled with Fecal Microbiota Transplant Placebo Formulation Keep Their Enteric Performance after Six Month Storage at -80°C

(W0930-01-02) Transdermal Delivery of Ultradeformable Cationic Liposomes Complexed with microRNA Prevents Transformation of Melanocytes to Melanoma

(T0930-01-06) Combatting Pseudomonas aeruginosa Biofilms: A Strategy with Glutathione-Conjugated Hydrogels for Disruption and Biofouling Mitigation

(W0930-03-13) Evaluating the Feasibility of Lyophilization for Oral Formulation Development of Monoclonal Antibodies (mAbs)

(W0930-03-16) Comparative Bioavailability Study of Jaspine B: Impact of Nano-Liposomal Drug Delivery System on Pharmacokinetics

(M0930-03-17) Heterologous Microneedle Vaccine Strategy for COVID-19

(M0930-03-18) Evaluating the Versatility of Klucel™ Xtend HPC in Dual Active Allergy Relief Extended-Release Dosages

(M0930-05-26) Advancing the Use of Chimeric Antigen Receptor T-cell Therapy (CAR T) in Glioblastoma Treatment

(T0930-05-26) On-Demand Multi-Indication Fast-Disintegrating Tablets for HIV Prevention and Birth Control: Formulation Development and In Vitro Evaluation

(T0930-05-27) Improving Lipid Nanoparticles Stability for mRNA Lung Delivery Through Nebulization

(W0930-05-28) Enhancing Oral Delivery of Alginate-Encapsulated Probiotics: The Novel and Versatile Role of Casein as an Excipient

(M0930-05-29) Exploring the Effect of Manufacturing Methods in Long-Acting Injectable Formulation Characteristics

(T0930-05-29) Pulmonary Delivery of mRNA via Engineered Chitosan Nanoparticles: Development and Application

(T0930-07-37) Development of Novel In Vitro Dissolution Assembly for Dissolving Microneedles via 3D Printed Mould - ImprintoGel

(M0930-07-37) Enabling Oral Delivery of Therapeutic Peptide Salmon Calcitonin: Impact of Hydrophobic Ion Pairs and Self-Nanoemulsifying Drug Delivery Systems on Proteolytic Protection and Pharmacological Activity

(W0930-07-37) Nanoparticle Development for Systemic Delivery of Resiquimod to Reactivate Immunosuppressive Tumor Microenvironment

(T0930-09-48) Cationic CaMKIIN-Loaded Liposomes that Reduce Chlorine-Induced Airway Oxidative Stress

(W0930-09-49) Biopharma Mixing Scale-Up: Small-Scale and Computational Studies

(W0930-09-52) Uncovering the Role of Risperidone Attributes on the In Vitro Release and Formation of In Situ Forming Implants

(T1030-01-02) Development of Novel Ionizable Lipid Nanoparticles for Enhanced siRNA Delivery

(T1030-01-03) Chitosan DNA Nanoparticle for PRPF31 Gene Delivery in Retinal Cell Line: Formulation and Characterization

(T1030-01-05) Development of Modality-Agnostic Strategies for High Concentration Biologic Candidate Selection

(T1030-01-06) The Influence of Nanostructural Characteristics on Gene Transfection: Enhanced DNA Delivery Through Macropinocytosis and Efficient Dissociation by Large, Botryoid-Shaped Nanoparticles

(M1030-03-13) Cationic Peptide Anchor-Mediated Binding to Tumor Extracellular Matrix Improves Intratumoral Retention of Agonist CD40 Antibody

(M1030-03-14) Enhancing Glycyrrhizin Delivery to White Adipose Tissue: A Promising Approach for Safe and Effective Obesity Treatment

(W1030-03-16) Predicting the Aggregation Behavior of Liposomes Using Thermal Analysis

(T1030-03-17) Lyoprotectants Affecting Product Stability of Lyophilized mRNA-Lipid Nanoparticles

(T1030-03-18) Optimization of Antibody Based Products Stabilized within a Film Matrix for Nasal Administration

(T1030-05-25) Enhancing Lyoprotectant Diversity via High-throughput Screening to the Boost Post-lyophilization Viability of Live Biotherapeutics

(M1030-05-25) Impact of Using 2-Hydroxypropyl-b-cyclodextrin (HPbCD) as an Excipient in Biologic Formulations on Solution Properties and Compatibility

(M1030-05-26) Co-Administration of a Novel Hedgehog Inhibitor and Anti-miR-96 in a Lipid-Based Nanosystem for the Treatment of Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD)

(M1030-05-30) Development of Nanosuspension Loaded Dissolving Microneedles for Delivery of a Novel Combination of Drugs for Treatment of Rheumatoid Arthritis

(T1030-07-37) Development, Characterization, and In Vitro Efficacy Evaluation of an Inhalable H1B Antimicrobial Peptide Formulation for Treating Non-Small Cell Lung Cancer

(W1030-07-37) Formulation with Hydroxypropyl ß-Cyclodextrin Preserves the Potency of Adenovirus Vectors Under Heat and Light Stress

(M1030-07-37) GRP78 Targeting of Long-Acting Hydra-Elastin-Like Polypeptides (ELPs) Carrying Rapamycin to Breast Cancer

(W1030-07-41) Phage-Antibiotic Loaded Coaxial Electrospun Fibres for Antibiotic Resistant Wound Infections

(W1030-09-48) Comparison of Plant and Animal Sources of Squalene as Adjuvants for Use in Vaccine Applications

(M1030-09-48) Polysaccharide Emulsion Gels for Reducing Postoperative Adhesions and Delivering 5-Fluorouracil

(T1030-10-54) Development of Dual-Ligand Nanoparticles for Systemic Chemoimmunotherapy of Cancer

(T1030-10-55) Development of Vaginal Thermosensitive Hydrogel for Enhanced Local Progesterone Delivery

(T1030-10-56) Optimized Aqueous Remote Encapsulation of Setmelanotide in PLGA for Monthly Controlled Release Treatment of Syndromic Obesity

(T1030-10-57) Dry Powders of a Rabies G Protein mRNA Vaccine Candidate Prepared by Thin-Film Freeze-Drying

(T1030-10-58) Rapid Development of High Concentration Protein Formulation Driven by High-Throughput Technologies

(M1030-10-59) Polymer Nanovectors for Treating Lung Inflammation

(T1130-01-03) Urolithin-A Laden Nanoparticles Upregulate Heme Oxygenase (HO-1) and Enhance Mitochondrial Quality Control in Mouse Model of Cisplatin-Induced Acute Kidney Injury

(T1130-01-04) Comprehensive Strategy for Type 2 Diabetes: Non-competitive Ligand-Based Oral Delivery of Curcumin Combined with Long-Acting Insulin to Prevent Secondary Complications

(T1130-03-16) Rational Design of Viscosity-Reducing Formulation Compositions for High-Concentration Protein Solutions

(M1130-03-17) Enhancing Gonorrhea Vaccine Efficacy: Dosage Response Analysis of a Novel Microparticulate Formulation

(W1130-03-17) Re-engineering of Lipid Nanoparticles Using Ionic Liquids for Brain Drug Delivery

(T1130-03-18) Leveraging Prior Knowledge for Drug Product Development: A Streamlined Lab-Scale Process Characterization Study Approach

(T1130-05-25) Hyper-Oxygenating Respiratoid Biosystem for Cell Transplantation

(M1130-05-26) Effect of Tumor Grade and Type on ECM-Liposome Interactions Measured by Contact Angle

(M1130-05-27) Evaluating the Efficacy of Polyoxyethylene Sorbitan as a Novel Surfactant in Biotherapeutic Antibody Formulations

(M1130-05-28) Understanding the Impact of L-leucine on Stability and Inhalation Potential of Dry Powder Protein Formulations

(T1130-07-37) Albumin Corona Improves Colloidal Stability of Nanosac, a Non-Cationic Polyphenol Gene Carrier

(W1130-07-37) Drug Product Development Approaches to Overcome Stability Challenges of Antibody Drug Conjugates (ADCs)

(M1130-07-37) Inflammatory Response to Lipopolysaccharide-Induced Injury and Treatment with Extracellular Matrix-Derived Nanoparticles

(M1130-07-38) An Assessment of Factors Influencing the Integrity of Sprayed-On Silicone Oil Layer in Prefilled Syringes and Functionality of Prefilled Syringes

(M1130-09-48) CCL2 Microparticles Modulate Host Immune Response in Periodontal Disease

(W1130-09-48) Comparing the Performance of Metronidazole Topical Gels with Variant Concentrations of Polyethylene Glycol (PEG) 400 in the Formulation

(M1130-09-49) Controlled Release of Proteins with Hydralese^® Formulations for Long-Acting Implants

(M1230-01-01) Power of a Diverse Analytical Toolbox for Polysorbate 80 Degradation Risk Assessment and Control: Case Study for Liquid Formulation Development

(W1230-01-03) Cellular Uptake of Bare and Corona Coated PEO-b-PCL and PEO-b-PBCL Micelles by HCT116 and SW620 Cell Lines

(M1230-01-05) Immobilization of Depolymerase Coating with Lay Down Bactericidal Activity on Biomedical Implants

(T1230-01-05) Polymeric Micelles for Nose-to-Brain Delivery of Rapamycin

(W1230-01-05) Vacuum Compression Molding: A Novel Method to Fabricate Drug-Loaded Microneedles for Three-Day Transdermal Delivery of Palonosetron Hydrochloride

(M1230-01-06) Development of Inhalable CXCR4 Targeted Polymeric Nanoemulsions for Delivery of RNAi Therapeutics to Enhance Anti-PD-L1 Immunotherapy in Lung Tumors

(W1230-01-06) Peptide Conjugated Hypoxia-Responsive Nanoparticles to Decrease Triple-Negative Breast Cancer Stemness in a Patient-Derived Xenograft Mice Model

(M1230-03-14) Quality by Design Guided Development of Hydrogel-Forming Microneedle Array Patches for Enhanced Transdermal Delivery of Biomimetic Peptide Enfuvirtide

(W1230-03-16) Vaccination Against Influenza Using Fast Acting 3D Printed Oral Dissolving Films as a Delivery System

(M1230-03-17) Pioneering the Targeted Brain Delivery of Aspirin to Elicit COX-1&2 Inhibition, Protecting from Ischemic Stroke and Neurodegeneration

(W1230-03-18) Harnessing Albumin-Anchored BRD4 PROTAC Nanoliposomes for Selective and Targeted Degradation in Pancreatic Ductal Adenocarcinoma

(T1230-03-18) Targeting Brain Metastasis in Non-Small Cell Lung Cancer with EGFRT790M Mutation Using BBB-Penetrating Codelivery Liposomes

(M1230-05-27) Dual Release of Lidocaine and Tizanidine from Coated and Monolithic Implants

(W1230-07-37) Hydroxypropyl Beta-Cyclodextrin as a Multifunctional Excipient for Downstream Processing and Formulation of Monoclonal Antibodies

(M1230-07-37) Local Controlled Delivery of an A3 Receptor Agonist Reduces Inflammation Associated with Contact Hypersensitivity

(T1230-07-38) Protein Stabilization Sweet Spot: Novel Class of Sugar-Based Excipients Enabling Downstream Processing and Formulation

(T1230-09-48) Development of Dissolving Microneedles for Delivery of Semaglutide for Treatment of Type 2 Diabetes and Obesity

(W1230-09-48) Understanding the Influence of Occlusion on Oxybutynin Permeation from a Transdermal Gel Deposited Film Using IVPT

(T1230-09-53) Development of siRNA Incorporated PEGylated and Polysorbate 80 Coated Polymeric Nanoparticles for Global Cerebral Ischemia

(M1230-10-54) 3D-Printed Microneedles Delivering Regulatory Immune Cues to Antigen-Presenting Cells in the Skin Promote Immune Tolerance

(T1230-10-54) Validation of the Potential of Oligoarginine-Linked Hyaluronic Acid as an Absorption Enhancer Through Animal Studies from Rodents to Primates

(T1230-10-55) The Influence of Combined Deaeration and Polysorbate 80 on IgG Denaturation during Thin-Film Freeze-Drying

(T1230-10-56) Nanosac Formulation for Nucleic Acid Delivery to the Brain

(M1230-10-58) Using AI-ML Modelling to Predict the Thawing Rates of Large Scale Frozen Protein Solutions

(T1330-01-02) Topical and Transdermal Delivery of 4-phenyl-butyric Acid Through Chitosan Nanoparticles Dispersed in a Foam Formulation: A Potential Antidote for Skin Injury Due to Chemical Warfare Agents

(M1330-01-03) Developing Lipid Nanoparticles (LNPs) for mRNA Delivery in Pancreatic Cancer (PC)

(M1330-01-04) The Non-GLP Dose Range-Finding Study on Lymphatic-Targeting of Cyclosporine in Mrl-lpr Mouse Model of SLE

(T1330-01-05) Exploring the Spatial Distribution of mRNA-Lipid Nanoparticles in Mouse Whole-Body and Isolated Organs Using MALDI MSI

(M1330-03-13) Artificial Extracorporeal Replicate for Drugs (AER_x): A Low-Cost Extracorporeal Membrane Oxygenator (ECMO) Mimic for High Throughput Drug Screening

(M1330-03-15) Thermal Stability and Controlled Release of Fattigated Vaccine Antigen in Human Serum Albumin Nanoparticle

(M1330-05-30) Investigating Partial Trehalose Crystallization During Lyophilization of Proteins

(T1330-07-37) Assessing the Influence of Quantitative Differences in Propylene Glycol on the Performance of Metronidazole Topical Gels

(M1330-07-37) Immunoactive Nanoparticle Boosted cDC1 for In Situ Cancer Immunotherapy

(M1430-01-01) Engineering Novel Antibody-Drug Conjugates with Dual Payloads to Improve the Incidence of Drug Resistance Associated with the Use of Antibody-Drug Conjugates in Oncology

(M1430-01-05) Formulation and Skin Delivery of Quercetin Loaded PAMAM Dendrimer-Based Gel for Potential Anti-Inflammatory and Antioxidant Effect

(M1430-03-13) Combination eEF2K Gene and Drug Delivery for Treatment of Breast Cancer

(T1430-03-13) Optimizing Protein Encapsulation Condition in Cholesterol-Modified Hyaluronic Acid (CHHA) Nanogels for Sustained-Release of APIs

(T1430-03-14) Delivery of mRNA-LNP Vaccine via Refrigerator-Stable Microneedle Array Patch

(T1430-03-15) FluoriPack Technology: A Non-aqueous Emulsification Process to Develop Polymeric Microspheres for Sustained Delivery of Biologics

(T1430-05-26) Lipid Nanoparticle Impurity Analysis: Leveraging Mass Spectrometry to Monitor Impurities and Aldehyde in Raw Materials and Formulated Drugs in Regulated Environments

(M1430-05-27) Self-Emulsifying NanoPODS (Nano-PND Oral Delivery Systems) for Oral Delivery of PND1186: In Silico Modeling for Bioavailability Estimation

(M1430-07-37) Intracellular Trafficking of Cationic Bicelles and siRNA Cargo in an In Vitro BBB Model

(M1430-09-48) Combining Arrhenius Kinetics and Monte Carlo Simulation to Enhance Stability Prediction for Antibodies

(T1430-09-48) Exploring Mannitol's Influence on Protein Stability: Spray-Dried rHGH Formulations

(M1530-01-01) Exploring AAV Capsid Aggregation: Molecular Simulations of Capsid Interactions in Varied Ionic and Surfactant Environments

(T1530-01-04) Evaluation of Process Parameters for Continuous Manufacturing of Quetiapine Fumarate Immediate Release Tablets Using Twin Screw Wet Granulation

(M1530-01-04) Exploring Drug Formulation Expert Perspectives on High-Concentration Subcutaneous Formulation Development: A Survey Analysis of Infrastructure, Stakeholder Preferences, and Perceptions

(M1530-03-13) ALD Nano Coating on Lyophilized and Spray Dried Biologics: Feasibility and Stability Improvement

(M1530-07-37) Optimization of 3D Printed Tablets Using Artificial Intelligence and Machine Learning

(T1530-07-38) Poloxamer 188 Variant for the Formulation of Biologics

(M1530-09-48) Dual Adjuvanted Ionizable Lipid Nanoparticles for Vaccine Delivery

(M1530-10-54) Development of an Aerosolizable Dry Powder of Mycobacteriophage D29 Using Thin-Film Freeze-Drying

(M1530-10-59) Antimicrobial Polymer-siRNA Polyplexes as a Dual-Mode Platform for the Treatment of Wound Biofilm Infection and Inflammation Control